Grant chasers...
Sounds like US DOD is happy with us so far, that's all that matters...
Will be happy to see another $4 mill USD in the coffers anyways..
TCG
"• Immuron’s request for AU$5.4M (US$4M) additional funding from the U.S. Department of Defense for Travelan considered to be ‘eligible for award’
• Travelan Investigational New Drug (IND) application advances
• Clinical trial Synopsis complete and plans in place to conduct a controlled human infection model (CHIM) clinical trial in 60 healthy volunteers in the USA Melbourne, Australia, April 19, 2022: Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the prevention and treatment of gut mediated pathogens, is pleased to advise that a new request for funding has been considered to be eligible for award by the US Department of Defense funding body ‘Medical Technology Enterprise Consortium’ (MTEC). Immuron is pursuing a regulatory pathway to license Travelan® with the Food and Drug Administration (FDA) via a Biologics License Application (BLA). The proposed indication is to reduce the risk of contracting travelers’ diarrhea caused by bacterial pathogens. The Company was recently awarded AU$4.8M (US$3.43M) by MTEC for the development of a Travelan® dosing regimen acceptable for use by the US military (ASX announcement 12 January 2022). In this new MTEC request for funding, Immuron is seeking an additional US$4M to fund the Investigational New Drug Application, CMC Assay Development and Validation, Nonclinical Safety Studies and Stability Studies required to support the BLA."
- Forums
- ASX - By Stock
- Ann: Immuron new MTEC project proposal
Grant chasers... Sounds like US DOD is happy with us so far,...
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMC (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.7¢ |
Change
0.001(1.32%) |
Mkt cap ! $17.64M |
Open | High | Low | Value | Volume |
7.6¢ | 7.7¢ | 7.6¢ | $9.584K | 124.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 18705 | 7.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 107508 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 18705 | 0.077 |
2 | 47642 | 0.076 |
3 | 137000 | 0.075 |
2 | 33500 | 0.074 |
1 | 100000 | 0.073 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 107508 | 1 |
0.081 | 500000 | 1 |
0.085 | 77613 | 2 |
0.086 | 147746 | 1 |
0.088 | 96511 | 2 |
Last trade - 11.16am 21/10/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online